Skip to main content

Table 1 Clinical data of all patients in this study

From: Fluorodeoxyglucose positron emission tomography/computed tomography findings after percutaneous cryoablation of early breast cancer

Clinical data

(n = 193)

Age (years), median (range)

57 (33–82)

Size (mm), median (range)

9 (2.5–15)

Pathology (IDC), n (%)

164 (85.0)

Lesion in right breast, n (%)

105 (54.4)

Duration between cryoablation and initial post-cryoablation PET/CT (months), median (range)

12 (2–36)

Radiation dose (Gy), median (range)

47.7 (39.6–60)

Boost to tumor bed, n (%)

42 (21.8)

Boost to tumor bed (Gy), median (range)

9 (2.5–12)

Duration between radiation and initial post-cryoablation PET/CT (months), median (range)

10 (3–33)

  1. IDC Invasive ductal carcinoma, PET/CT Positron emission tomography/computed tomography